1069 IL-12 mRNA monotherapy is effective in murine tumors resistant to checkpoint inhibition

1069 IL-12 mRNA monotherapy is effective in murine tumors resistant to checkpoint inhibition

Bibliographic Details
Main Authors:	Katerina Politi, Marcus Bosenberg, Man Li, Jim Eyles, Sreevidya Santha, Jayalakshmi Lakshmipathi, Yuping Qian, Nadia Luheshi, Viswanathan Muthusamy
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Is 1069 a Name?
by: Thomas M. Lockney, et al.
Published: (1981-03-01)

Genetic characterization of novel class 1 Integrons In0, In1069 and In1287 to In1290, and the inference of In1069-associated integron evolution in Enterobacteriaceae
by: Dongguo Wang, et al.
Published: (2017-08-01)

Achtes Buch (Kapitel IV) (Seite 1069-1082)
by: Johann Johann Baptist von Spix, et al.
Published: (2023-03-01)

Indian Journal of Dermatology (IJD®) gets its first impact factor of 1.069
by: Koushik Lahiri
Published: (2017-01-01)

P1069: RETROSPECTIVE COMPARISON OF PATIENT OUTCOMES ON PACRITINIB VERSUS RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS AND THROMBOCYTOPENIA
by: C. Harrison, et al.
Published: (2022-06-01)

Ciudades y urbanismo en el Egipto antiguo (CA. 3000-1069 a.c.)
by: Andrés DIEGO ESPINEL
Published: (2010-02-01)

Transcriptomic signature of Bexarotene (Rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models
by: Bissonnette Reid P, et al.
Published: (2008-09-01)

Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined Therapies
by: Tao Ouyang, et al.
Published: (2022-06-01)

Angiotensin I-converting enzyme Gln1069Arg mutation impairs trafficking to the cell surface resulting in selective denaturation of the C-domain.
by: Sergei M Danilov, et al.
Published: (2010-01-01)

Sains Sebagai Asas Pembinaan Tamadun: Kajian Terhadap Kitab Tabaqat Al-Umam Oleh Sa‘Id Al-Andalusi (1029-1069)
by: Mohd Ali, Mohd Zamrus
Published: (2017)

Immune Checkpoint Inhibitors as Monotherapy or Within a Combinatorial Strategy in Advanced Hepatocellular Carcinoma
by: Michela Guardascione, et al.
Published: (2020-08-01)

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy.
by: Eugene B Cone, et al.
Published: (2022-01-01)

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy
by: Eugene B. Cone, et al.
Published: (2022-01-01)

Performance Evaluation on Selection of Formwork Systems in High Rise Buildings Using Regression Analysis and Their Impacts on Project Success
by: Rajeshkumar Viswanathan, et al.
Published: (2019-06-01)

CD47-Dependent Regulation of Immune Checkpoint Gene Expression and MYCN mRNA Splicing in Murine CD8 and Jurkat T Cells
by: Sukhbir Kaur, et al.
Published: (2023-01-01)

Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases
by: Pankti Reid, et al.
Published: (2023-12-01)

Liver metastasis affects progression pattern during immune checkpoint inhibitors monotherapy in gastric cancer
by: Iori Motoo, et al.
Published: (2023-09-01)

Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer
by: Shijia Zhang, et al.
Published: (2021-03-01)

P1069: GONADAL FUNCTION AND FERTILITY PRESERVATION IN PEDIATRIC PATIENTS WITH HODGKIN LYMPHOMA TREATED ACCORDING TO THE EURONET-PHL-C2 PROTOCOL: THE FERTILITY ADD-ON STUDY
by: Katja Drechsel, et al.
Published: (2023-08-01)

Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma
by: Abhishek D. Garg, et al.
Published: (2017-04-01)

PD-1 Immune Checkpoint Inhibitor Therapy Malignant Tumor Based on Monotherapy and Combined Treatment Research
by: Yu Zhang, et al.
Published: (2021-03-01)

Efficacy and safety of immune checkpoint inhibitor monotherapy in elderly patients with non‐small cell lung cancer
by: Yasuhiro Chikaishi, et al.
Published: (2021-03-01)

Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers
by: Noura J. Choudhury, MD, et al.
Published: (2021-07-01)

Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators
by: Hwa Kyung Byun, et al.
Published: (2021-05-01)

MUTATIONS H1069Q OF ATP7B GENE AND C282Y AND H63D OF HFE GENE IN PERSONS WITH HEPATOBILARY DISEASES OF UNDEFINED GENESIS
by: Haiboniuk I. I., et al.
Published: (2019-04-01)

<it>In vitro </it>anti-angiogenic properties of LGD1069, a selective retinoid X-receptor agonist through down-regulating Runx2 expression on Human endothelial cells
by: Lu Hong, et al.
Published: (2011-06-01)

DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR
by: Goran Micevic, et al.
Published: (2016-03-01)

Profiling renal sodium transporters in mice with nephron Ift88 disruption: Association with sex, cysts, and blood pressure
by: Chunyan Hu, et al.
Published: (2022-03-01)

High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis
by: Julliana Ribeiro Alves Santos, et al.
Published: (2017-07-01)

SG-APSIC1069: Implementing infection prevention bundle significantly reduced multidrug-resistant organisms infection and healthcare-associated infections in intensive care unit at a national hospital in Vietnam
by: Thang Phung, et al.
Published: (2023-02-01)

Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with <i>ALK</i> Rearrangement
by: Yuko Oya, et al.
Published: (2020-04-01)

Isotope tracing reveals distinct substrate preference in murine melanoma subtypes with differing anti-tumor immunity
by: Xinyi Zhang, et al.
Published: (2022-12-01)

Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma
by: Taylor E. Woo, et al.
Published: (2023-09-01)

Differential Dermatologic Adverse Events Associated With Checkpoint Inhibitor Monotherapy and Combination Therapy: A Meta-Analysis of Randomized Control Trials
by: Yang Ge, et al.
Published: (2021-07-01)

ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis
by: Haruki Horiguchi, et al.
Published: (2023-09-01)

1530 T-cell responses to individualized neoantigen therapy (INT) mRNA-4157 (V940) as monotherapy or in combination with pembrolizumab
by: Wei Zheng, et al.
Published: (2023-11-01)

1339 Systemically administered onco-selective mRNA LNP achieves tumor regression and improves overall survival, as monotherapy
by: Manfred Kraus, et al.
Published: (2023-11-01)

Erratum: Borejko, T., et al. NaviSoC: High-Accuracy Low-Power GNSS SoC with an Integrated Application Processor. <i>Sensors</i> 2020, <i>20</i>, 1069
by: Tomasz Borejko, et al.
Published: (2020-09-01)

Assessing the impact of mRNA vaccination in chronic inflammatory murine model
by: Seonghyun Lee, et al.
Published: (2024-02-01)

Cognitive adverse events in patients with lung cancer treated with checkpoint inhibitor monotherapy: a propensity score-matched analysisResearch in context
by: Yifei Ma, et al.
Published: (2023-05-01)